Multistakeholder Development Partnerships: Harnessing Differing Perspectives, Objectives, and Strengths for Success
Track
:
Track 03: Innovative Partnering Models and Outsourcing Strategies
Program Code:
404
Date:
Thursday, June 28, 2012
Time:
9:00 AM to 10:30 AM
EST
CHAIR
:
Karen Jaffe, Alfred Mann Biomedical Engineering Institute, United States
Over 25 year in technology, managed the Argus Suite of products and currently serving as Director of Product Strategy for Oracle's Pharmacovigilance Analytics products.
PRESENTER
(S):
Karen Jaffe, Alfred Mann Biomedical Engineering Institute, United States
Over 25 year in technology, managed the Argus Suite of products and currently serving as Director of Product Strategy for Oracle's Pharmacovigilance Analytics products.
Karl Whitney is Director of Product Development at Rho, Inc. He has a decade’s experience as an integrated product development program manager, planning and overseeing the manufacturing, nonclinical, clinical, and regulatory activities that make up a well-functioning product development program.
Xia Xu, Merck Research Laboratories, United States
I joined Merck as Biometrician on December 2005 and received my Ph.D degree in Statistics from Iowa State University on May 2006. My primary responsibility at Merck is to design and analyze late stage clinical trials, mostly in the area of HIV infection.
Description
The symposium will use case studies to detail operational lessons with integration of multiple stakeholders in medical development processes. Innovation centers bridge gaps between biomedical invention and creation of successful products that improve lives.
Learning Objectives: Discuss the use of effective partnering to leverage complementary skillsets and resources Examine partnership challenges with clinical trial conduct, data management, analysis and reporting, publication and regulatory submission.